An in vitro system for the production of integrative recombinant DNA of bacteriophage X is described. The in vitro recombination mimics the in vivo integration of viral DNA into host DNA in its requirement for int gene product, for the presence of a thermolabile component, and for the limitation of the recombination to a pair of specialized sites (attachment sites) on the DNA. The enzymes are extracted from Escherichia coli containing phage X gene products. The substrate is the DNA from XattB-attP, a phage variant that contains two attachment sites on the same chromosome. The product is a recombinant phage chromosome that has lost the DNA between the attachment sites. The parental and recombinant DNA are distinguished following transfection to mature phage in spheroplasts. The reaction requires ATP, Mg++, spermidine, and a monovalent cation. Recombination occurs preferentially between attachment sites on the same molecule. The enzymatic activity is completely inhibited by extracts containing xis gene product.
results in an integrated prophage, flanked by attachment sites attL and attR. Site-specific recombination between prophage attachment sites, leading to excision of the prophage and creation of attP and attB, requires the products of X genes int and xis (1) .
A variant of phage X, XattB-attP, carries both of the attachment sites involved in insertion (Fig. 1) . Following infection of suitable hosts, XattB-attP undergoes integrative recombination at high frequency. The resulting recombinant phage, XattL, is deleted from 13.5% of the parental genome (2) ; the presence of the deletion permits XattL to be distinguished from XattB-attP by survival of plaque-forming activity in the presence of chelating agents, e.g., pyrophosphate (3) . Previous work has shown that recombinant DNA derived from XattBattP can be detected by conversion of the DNA to mature phage in spheroplasts followed by analysis of the mature phage for inactivation by pyrophosphate (4) . Using this transfection assay, I have developed an in vitro system for the production of integrative recombinant DNA from XattB-attP DNA.
MATERIALS AND METHODS
Strains. The bacteria used are derivatives of E. coli K12. N99rec+su-is Meselson strain 28. AB2470 (5) carries the recB21 allele that inactivates exonuclease V. N2941 is CR63X' Xh8 (Xh8Oimm21); this strain is used to detect phage X carrying the extended host range allele, h, and an immunity different from that of phage 21. The xis6 allele is described by Guarneros and Echols (6) . Xh int-c cI857 was provided by R. Weisberg from K. Shimada. The int-c mutation specifically derepresses the int gene in an uninduced lysogen and inactivates the xis gene (7) . All other bacterial strains and bacteriophage alleles are described in ref. 4. Growth of Cells and Preparation of Cell Extracts. The method used is a modification of that described by Wickner et al. (8) .
All growths were in TBY (1% tryptone, 0.5% yeast extract, 0.5% NaCl) at 310. A The proportion of recombinant phage DNA in the nucleic acid extracts of the reaction mixtures was determined as previously described (4) . Briefly, the nucleic acid extracts were used to transfect spheroplasts of strain KL176 su-recAl recB2lXr. After lysis of the spheroplasts, released phage were assayed on nonselective and pyrophosphate-containing plates. The proportion of transfected phage resistant to the chelating agent is taken as the proportion of recombinant phage DNA. Phage bursts from 75 to 200 infected spheroplasts were used for each determination.
Preparation of DNA. Purified stocks of phage were prepared as described previously (4) . Phage DNA was prepared by rolling a suspension of phage (ODu0 = 1-3) with phenol which had been equilibrated with TE; the extraction was repeated twice. The extracted DNA was dialyzed exhaustively against TE. Aliquots of phage DNA were converted to the hydrogen bonded cyclic form by the method of Wang (10) . Phage DNA at 10,ug/ml in 2 M NaCl containing 0.01 M Na2EDTA and 0.05 M Tris -HCl (pH 8.0) was heated to 75°, chilled in ice for 5 min, and incubated at 500 for 2 hr. The annealed DNA was chilled, concentrated by dialysis against dry sucrose, and dialyzed against 0.05 M Tris-HCl (pH 8) containing 0.001 M Na2EDTA arnd 0.002 M MgCl2.
RESULTS
The in vitro reaction uses the elements of in vivo integrative recombination
Integrative recombination in vivo requires the product of the int gene and is extremely thermolabile (11). Another characteristic feature of integrative recombination in tiw is limitation of the recombination to attP and attB (1) . Genetic analysis of the transfected recombinant phages indicates that they are derived from genomes that have been deleted for the genetic material lying between the attachment sites and have retained all other genes. All pyrophosphateresistant phage tested (12/12) carried the host range, galactose transducing, and immunity marker of the parent strain: Table 2. all had lost the ability to transduce markers in bioA and bioD genes. Furthermore, five clones of phage derived from different recombinant DNA molecules were characterized by buoyant densities in CsCl which were equal to each other and identical to that observed for XattL produced in vice. Since phage buoyant density is determined by the length of XDNA in the virion (12) , the deletion produced in vitro must be of the same physical length as that produced in vivo.
The X integrative recombination reaction in vitro
The requirements for integrative recombination of XattB-attP DNA by DEAE-cellulose treated, dialyzed cell-free extracts are shown in Table 2 . Recombination shows an absolute dependence on the presence of spermidine, Mg++ and ATP. The a-j methylene analog of ATP is unable to replace the ATP requirement, indicating that ATP hydrolysis is required for the reaction. A role for ATP is also suggested by the monovalent cation requirement, which is frequently associated with enzymes that catalyze phosphoryl transfer reactions (13). The kinetics of production of integrative recombinant DNA in vitro is shown in Fig. 2 . After a delay of 5-10 min recombinant DNA is produced for about 20 min. The relation between the kinetics of in vivo and in vitro recombination is discussed below.
The variation of activity as a function of the amount of cellfree extract is shown in Table 3 . The response is roughly linear over the range tested. Table 3 also shows that 10-50%o of the infectivity of the added DNA is recovered from the reaction mixture. The loss of infectivity of added DNA is not a consequence of the recombination reaction since similar recovery of infectivity is obtained when extracts that are inactive in integrative recombination are used. Much lower recovery of infectivity is obtained if the added DNA is in the linear form, with exposed cohesive ends, rather than in the hydrogenbonded cyclic form. Preliminary experiments indicate that even with hydrogen-bonded cyclic DNA, the major pathway for loss of infectivity is through damage to the cohesive ends of the phage DNA.
In vitro recombination is intramolecular
The relative contributions of recombination between attachment sites on the same DNA molecule and recombination between attachment sites on two separate DNA molecules are analyzed in the following way. Suppose a mixture of two genetically marked strains of XattB-attP DNA is used as the substrate in an in vitro recombination reaction. If integrative recombination were entirely intermolecular, 1/2 of the deleted DNA molecules would result from integrative recombination between parental molecules with differing pairs of outside markers. On transfection 1/2 of these molecules would yield pyrophosphate-resistant phage carrying a selected pair of markers. If integrative recombination were entirely intramolecular, no deleted molecules would be recombinant for outside markers. Table 4 shows that in such an experiment, no transfected phage are found to be recombinant for the markers tested. Analysis of these data by a simplified ViscontiDelbruck method (2) shows that intermolecular recombination is at least 25-fold less frequent than intramolecular re- 6, 8) . This rules out the possibility that the inhibition is governed by a gene which is activated only following excision and circularization of the prophage. Therefore, the inhibitor must be xis gene product or some direct byproduct of the action of xis gene product.
DISCUSSION
Many features of the in vitro production of recombinant DNA described in this work agree with the characteristics of integrative recombination in X-infected cells. For example, the requirements for int gene product, the existence of a highly thermolabile element, and the limitation to attachment sites are identical in both systems. Furthermore, the requirement for ATP and the inhibition by xis gene product have both been inferred from studies on production of recombinant DNA by cells which have been infected with XattB-attP (4). One feature of integrative recombination in vitro which differs from in vivo behavior is the kinetics of the reaction. Cells infected with XattB-attP phage begin to produce recombinant DNA after a 10-to 15-min lag. If the genetic expression of the The reaction mixture contained 0.25 mg of extract prepared as described in Table 2 . The substrate was a mixture of 0.2 jig each of XattB-attP int2xislredll4imm434c and XattBattP h int2xisIred114imm21c DNA. Each reaction was incubated for 20 min at 310. The transfected phage derived from each reaction mixture was assayed for genetic content by plating aliquots on nonselective or pyrophosphate-containing plates and stabbing individual plaques to lawns of N99(21 gp), to determine immunity type, and to lawns of N2941, to detect phage recombinant for host range and immunity alleles. infecting phage is blocked by repressor or by rifampin and chloramphenicol, the lag is removed and the production of recombinant DNA starts immediately after injection of the phage DNA (4). The 5-to 10-min lag in appearance of recombinant DNA in vitro (Fig. 2) is unexpected since neither transcription nor translation should occur under the conditions used in vitro. Furthermore, no change in the kinetics of recombination in vitro is seen on addition of 10 gg/ml of rifampin and 5 1ug/ml of chloramphenicol (data not shown).
The in vitro delay may reflect an alteration, with respect to in vivo conditions, in the amount or accessibility of a component required for an early step in the recombination process. The analysis of the kinetics of recombination after preincubation with various separated components may illuminate the nature of this early step.
Little is known about the structure of the product of the in vitro recombination reaction. I3ecause the assay involves conversion of DNA to phage in spheroplasts of nonlysogenic cells, any infectious DNA which has been acted on by all the phage genes involved in integration will be counted as recombinant DNA. Two specific kinds of DNA structures have been shown not to be important products of this reaction. DNA molecules with double-stranded breaks are ruled out since the infectivity of both total and recombinant DNA extracted in the assay procedure is linear over at least a 10-fold variation in the amount added to spheroplasts. [DNA molecules with double-stranded breaks show a second order dependence of infectivity on the concentration of phage DNA (14)1. DNA molecules with nicks or gaps separated by short double helical regions are ruled out since the recombinant proportion of transfected phage is unaffected by heating nucleic acid extracts of assay mixtures to 970 for 3 min in 0.3 M NaCl.
This treatment has been shown to break such "joint molecules" and would lower their infectivity (15) . The determination of the recombinant structures produced under normal and abnormal assay conditions remains an important goal.
The inhibition of integrative recombination which is dependent on xis gene product is, as mentioned above, one of several points of similarity between the behavior of integrative recombination in vitro and that observed in infected cells. It should be pointed out that in vivo, this inhibition is only observed in the presence of inhibitors of macromolecular N99(Xb2 xis +) + AB2470(X int-c) <0. 1 The reaction described in lines 1-3 contained 1 mg of extract derived for the indicated lysogen. All other reactions contained 0.2 mg of extract of each cell type listed. In addition to the phage genes indicated, all prophages in N99 also carried the h, cI857, and susP3 alleles; these lysogens were thermally induced prior to extraction. The prophage in AB2470 also carried the h and cI857 alleles; these lysogens were not induced. synthesis. Several ways in which this effect of xis gene product might be overcome after phage infection of growing cells have been discussed elsewhere (4) . The inhibition dependent on xis gene product may prove to be a useful tool in analyzing the mechanism of the in vitro integrative recombination reaction. The inhibition is not the result of a simple rejoining of the separated products of the integration reaction (shown as the upward reaction in Fig. 1 ). Such a reverse reaction would require recombination between attachment sites on different molecules, and intermolecular recombination has been shown above to be very inefficient, at least for integrative recombination. In addition, the reverse reaction cannot be demonstrated to occur between the putative attR segments and added XattL DNA carrying distinguishing markers (data not shown). If the inhibition is by reversal of the integrative reaction, it occurs at a stage prior to the separation of the products into independent pieces of DNA. Alternatively, the inhibitor might directly affect integrative recombination by altering int gene product, other enzymatic components, cofactors, or the parental attachment sites.
Seyeral systems for the production of recombinant DNA in vitro have been reported recently. Most of these (15) (16) (17) have not attempted to reproduce a naturally occurring pathway of recombination and are not directly comparable to the present work. An in vitro system which uses naturally occurring pathways for the combined recombination and packaging of bacteriophage XDNA has been recently reported by Syvanen (18) . This system differs from the one described in the present work in two fundamental ways. First, different modes of site-specific recombination are studied. The system described by Syvanen appears to involve site-specific recombination between two copies of attP (18) : the present work uses site-specific recombination between attP and attB. Although these recombinations both require int gene product, they probably involve distinct enzymatic pathways since they show markedly different responses to xis gene product and the thermolabile element (11) . Second, in contrast to the system described by Syvanen, the present work uses enzymes which are prepared separately from the substrate DNA and separates the reaction that produces recombinant DNA from the step in which recombinant DNA is converted to a detectable form. These features make the in vitro system for integrative recombination especially well suited for the separation and analysis of the component enzymes required for recombination. In a separate study, Gottesman and Gottesman have used methods similar to those described here for demonstration of the in vitro production of site-specific excisive recombinant DNA from a substrate carrying the prophage attachment sites attR and attL (personal communication).
